Development and Characterization of a Luminescence-Based High-Throughput Serum Bactericidal Assay to Assess Bactericidal Activity of Human Sera against Nontyphoidal ISalmonella/I

Salmonella Typhimurium and Salmonella Enteritidis are leading causative agents of invasive nontyphoidal Salmonella (iNTS) disease, which represents one of the major causes of death and morbidity in sub-Saharan Africa, still partially underestimated. Large sero-epidemiological studies are necessary t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Methods and protocols 2022-12, Vol.5 (6)
Hauptverfasser: Aruta, Maria Grazia, De Simone, Daniele, Dale, Helen, Chirwa, Esmelda, Kadwala, Innocent, Mbewe, Maurice, Banda, Happy, Gordon, Melita, Pizza, Mariagrazia, Berlanda Scorza, Francesco, Nyirenda, Tonney, Canals, Rocío, Rossi, Omar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Salmonella Typhimurium and Salmonella Enteritidis are leading causative agents of invasive nontyphoidal Salmonella (iNTS) disease, which represents one of the major causes of death and morbidity in sub-Saharan Africa, still partially underestimated. Large sero-epidemiological studies are necessary to unravel the burden of disease and guide the introduction of vaccines that are not yet available. Even if no correlate of protection has been determined so far for iNTS, the evaluation of complement-mediated functionality of antibodies generated towards natural infection or elicited upon vaccination may represent a big step towards this achievement. Here we present the setup and the intra-laboratory characterization in terms of repeatability, intermediate precision, linearity, and specificity of a high-throughput luminescence-based serum bactericidal assay (L-SBA). This method could be useful to perform sero-epidemiological studies across iNTS endemic countries and for evaluation of antibodies raised against iNTS vaccine candidates in upcoming clinical trials.
ISSN:2409-9279
2409-9279
DOI:10.3390/mps5060100